Stay updated on IGN002 Clinical Trial in Refractory NHL
Sign up to get notified when there's something new on the IGN002 Clinical Trial in Refractory NHL page.

Latest updates to the IGN002 Clinical Trial in Refractory NHL page
- Check6 days agoChange DetectedThe new screenshot shows visual/UI layout changes without modifications to core study information such as eligibility criteria, endpoints, or patient data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check13 days agoNo Change Detected
- Check35 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference5%

- Check42 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

- Check56 days agoChange Detected- Revision updated to v3.0.2 (replacing v3.0.1); no substantive content changes. The 'Back to Top' link was removed.SummaryDifference0.3%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.3%

- Check71 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while removing specific geographic details and a resource related to Lymphosarcoma.SummaryDifference2%

Stay in the know with updates to IGN002 Clinical Trial in Refractory NHL
Enter your email address, and we'll notify you when there's something new on the IGN002 Clinical Trial in Refractory NHL page.